With World Health Day around the corner on April 7th, we’d like to bring attention to the intersection of global health and digital identity, and specifically the opportunity for immunization rates to scale digital identity amongst the most hard-to-reach children.
Globally, an estimated 95% of children receive at least one dose of some vaccine. This number is staggering — no other public health intervention reaches more children and impacts more families.
Yet, despite this high initial contact rate, only 37% of children in the world’s poorest countries are fully immunized, meaning that they receive their full course of recommended vaccines. Ultimately, many children are left without comprehensive protection and vulnerable to many vaccine-preventable diseases.
Percentage of children reached with the last dose of seven vaccines recommended across all Gavi-supported countries and of three vaccines specific to certain regions (Source: Gavi 2016 Annual Progress Report http://www.gavi.org/progress-report/)
There are several reasons for low coverage rates, including the low quality of population data and reliance on outdated systems to track immunizations, but one critical challenge is the continued use of paper-based systems to record the doses that have been administered and indicate when a child needs to return for boosters. Unfortunately, the paper records kept within a clinic are often difficult to analyze and the immunization cards given to families are prone to loss and inaccuracies. Without a persistent, portable record that can be uniquely linked to the child, it’s often difficult to ascertain the care a child needs.
In November, Dr. Seth Berkley, CEO of Gavi, the Vaccine Alliance, wrote a piece for Nature that emphasized the pressing need to move to digital systems — specifically those to identify and track those currently missing out — to achieve 100% immunization coverage.
One of the biggest needs is for affordable, secure digital identification systems that can store a child’s medical history, and that can be accessed even in places without reliable electricity. That might seem a tall order, but it is both achievable and necessary.
This message was reinforced at this year’s World Economic Forum meeting in Davos, Switzerland, where Gavi announced digital identity as the focus for its 2018 INFUSE program. INFUSE — Innovation for Uptake, Scale and Equity in Immunization — aims to identify and support innovative solutions that have the potential to modernize global health and immunization delivery. This year, Gavi is focusing its efforts on identifying opportunities for digital identity technologies to help facilitate better targeting, follow-up, and immunization service delivery for the world’s most vulnerable children.
Immunization poses a huge opportunity to scale digital identity — in many developing countries, immunization coverage greatly exceeds birth registration rates. According to best available estimates, upwards of 95% of children globally receive at least one dose of one vaccine (with 86% of children globally receiving the full three doses recommended of the diphtheria-tetanus-pertussis vaccine, which is commonly used to measure immunization coverage).
When a child receives her first vaccine, she receives a paper child health card. In many developing countries, the most common form of identification is not a birth certificate, but this card. The near ubiquity of these documents presents an enormous opportunity.
Moving from easily lost or damaged paper health cards to an accessible digital form would reduce the burden associated with tracking a child’s vaccines and eliminate redundant or unnecessary paperwork. Digital child health cards can improve coverage rates and vaccine compliance by prompting parents to bring their children in for necessary subsequent doses. For health workers, digital identity technology validates a child’s past vaccines and may streamline analytics and outreach, without adding significant complexity to a health worker’s workflow. And for Gavi and its international partners, digital ID technology provides a basis for a system of verifiable proofs and accurate aggregate data that interoperates with other identity management systems, negating the need for each organization to independently identify beneficiaries.
And because immunization is conducted in infancy, providing children with a digital child health card would give them a unique, portable digital identity early in life. And as children grow, their digital child health card can be used to access secondary services, such as primary school, or ease the process of obtaining alternative credentials. Effectively the child health card becomes the first step in establishing a legal, broadly recognized identity.
In turn, having a persistent and portable health record uniquely tied to the child will help to increase full immunization coverage rates by prompting follow-up and better targeting the most hard to reach children.
In order to enable digital identity at scale, we will need to identify and leverage many entry points. Immunization service delivery presents a tremendous opportunity to provide children with a durable, portable and secure digital identity early in life, enabling access to a wider range of social services, while also improving access to the health interventions all children need and deserve.
We’re proud to partner with Gavi and excited to see the innovations proposed as part of the INFUSE Challenge. To all innovators: the deadline to apply for the program is April 10th, so please get those applications in!
INFUSE 2018 is calling for proven digital technology innovations — adapted to low-resource environments in developing countries — to help identify and register children, especially girls, who are at risk of missing out on life-saving vaccines.
Launched at Davos in 2016, Innovation for Uptake, Scale and Equity in Immunisation (INFUSE) helps improve vaccine delivery systems by connecting high-impact, proven innovations with the countries that need them most. It then “infuses” them with capital and expertise to help take them to scale.
“Since 2016, ID2020 has advocated for ethical, privacy-protecting approaches to digital ID.
For the one in seven people globally who lacks a means to prove their identity, digital ID offers access to vital social services and enables them to exercise their rights as citizens and voters and participate in the modern economy. But doing digital ID right means protecting civil liberties and putting control over personal data back where it belongs…in the hands of the individual.
Every day, we rely on a variety of forms of identification to go about our lives: our driver’s license, passport, work badge and building access cards, debit and credit cards, transit passes, and more.
But technology is evolving at a blinding pace and many of the transactions that require identification are today being conducted digitally. From e-passports to digital wallets, online banking to social media accounts, these new forms of digital ID allow us to travel, conduct business, access financial and health records, stay connected, and much more.
While the move to digital ID has had many positive effects, it has been accompanied by countless challenges and setbacks, including large-scale data breaches affecting millions of people. Most of the current tools are archaic, insecure, lack appropriate privacy protections and commoditize our data. But that’s about to change and ID2020 is leading the charge.
We are businesses, nonprofits, governments and individuals…working in collaboration to ensure that the future of digital identity is, indeed, #goodID.” – ID2020.org
Gavi and Zenysis Technologies to bring data and artificial intelligence to immunisation programmes
The partnership supported by Asia’s largest internet services company Tencent will help developing countries reach more children with life-saving vaccines
Geneva, 12 March 2019 – Gavi, the Vaccine Alliance and Zenysis Technologies, a Silicon Valley startup, have established a new strategic partnership that will help low-income countries harness the power of big data and artificial intelligence to improve childhood vaccination programs around the world.
Zenysis Technologies was identified by Gavi, through the INFUSE (Innovation for Uptake, Scale and Equity in Immunisation) yearly call for innovation. INFUSE aims to identify proven solutions which, when brought to scale, have the greatest potential to modernise global health and immunisation delivery.
What the team at Zenysis has built and accomplished to date is in a class of its own.
David Wallerstein, Tencent’s Chief Exploration Officer
A two-year partnership will provide countries with the Zenysis’ software platform, analytical training and IT skills development. Countries will use the platform’s capabilities to integrate data from their fragmented information systems and help decision-makers see where children are not receiving vaccines. Advanced analytics will then help countries decide how to target their limited resources for maximum impact.
“Weak immunisation data leads to poor planning, often meaning that children, whether they live in urban slums or remote rural outposts, miss out on lifesaving vaccines. Digital transformation of immunisation data and analytics is key to making sure that all children are protected from vaccine-preventable diseases,” said Gavi CEO Dr Seth Berkley. “Our partnership with Zenysis has the potential to increase efficiency and reduce costs for developing countries but, most importantly, it could save lives.”
Since its inception three years ago, Zenysis has expanded into ten countries that now use its software to improve health programs serving over one billion people. The company’s software has been used to optimise nationwide vaccination campaigns allowing for reinvestment in other lifesaving health programs.
“Gavi, the Vaccine Alliance has helped over 70 countries vaccinate more than 700 million children in low income countries,” said Zenysis CEO, Jonathan Stambolis. “However, weak and fragmented information systems at the country level mean that millions of the world’s most vulnerable children have been left behind. We have assembled one of the strongest software engineering teams in Silicon Valley to build the software countries need to address this urgent global health challenge and our partnership with Gavi and Tencent will ensure that technology benefits the countries that need it most.”
We have assembled one of the strongest software engineering teams in Silicon Valley to build the software countries need to address this urgent global health challenge…
Jonathan Stambolis, Zenysis CEO
The company expects to reach at least fifteen more countries in 2019. This will include Pakistan, where Zenysis will be working with government authorities and Gavi to improve vaccination coverage and equity as well as to accelerate the country’s progress towards a polio-free future. The project has the backing of one of Zenysis’ investors, internet services giant Tencent Holdings, Asia’s largest company. Tencent investment of US$ 4.5 million will be matched by the Gavi Matching Fund.
“We are very excited about the potential for artificial intelligence to transform child health on a global scale”, said David Wallerstein, Tencent’s Chief Exploration Officer. “I look at hundreds of the fastest-growing startups every year. What the team at Zenysis has built and accomplished to date is in a class of its own. The company’s software will help governments become more effective and targeted at every step of the vaccination challenge, and move with the urgency and speed required to realise Gavi’s vision of a world free of vaccine-preventable illnesses”.
The official Memorandum of Understanding establishing this landmark partnership between Gavi and Zenysis Technologies was signed by Gavi’s CEO Dr Seth Berkley and the Zenysis CEO Jonathan Stambolis in Abu Dhabi during the Gavi Mid-Term Review high-level conference.
2008: Klaus Schwab presents his vision of a ” Global Corporate Citizenship”
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
THERE’S NO BETTER PREVENTION THAN SHARING THE KNOWLEDGE FASTER THAN THEY SHARE THEIR PROPAGANDA!
The original title of this article was URGENT! DEBUNKING THE NEXT ENGINEERED PANDEMIC: NIPAH VIRUS. I expanded the scope because in the meantime I learned they are ramping up propaganda for all three. These viruses have more things in common, as you will find out below.
You should actually begin with this earlier report:
To further develop the ChAd3 Ebola and Marburg vaccines, Sabin has entered into a Research Collaboration Agreement with the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases. The Sabin Vaccine Institute, a non-profit organization founded in 1993, is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation. Sabin received more than $110 million for vaccine R&D programs from public and philanthropic funding sources, including the Bill & Melinda Gates Foundation, European Commission, Dutch Ministry of Foreign Affairs, Global Health Innovative Technology Fund and the Michelson Medical Research Foundation.
Washington DC, Oct. 21, 2021 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute (Sabin) announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, has exercised the third contract option, valued at $34.5 million, under the 2019 contract to advance the development of vaccines against Ebola Sudan and Marburg viruses through Phase 2 clinical trials.
In September 2019, BARDA awarded Sabin a development contract, valued up to $128 million, and has already provided funding of $40.5 million. This third contract option will enable continued nonclinical efficacy and safety studies, Phase 2 clinical trials in Africa, and vaccine manufacturing processes to ensure quality and safety.
In August, a case of Marburg disease was confirmed in the West African country of Guinea where the Ministry of Health officially declared an outbreak of Marburg.1 This recent case, as well as Marburg’s history of outbreaks and their potential for future devastating outbreaks, demonstrates that preventative measures are overdue to protect civilian populations, military personnel, first responders, health care workers and laboratory workers, both in the United States and abroad, against these emerging infectious diseases.
Ebola Sudan and Marburg viruses are closely related to Ebola Zaire virus, which has caused more than 2,200 deaths since 2018, leading the World Health Organization (WHO) to declare it a Public Health Emergency of International Concern. Like Ebola Zaire, Ebola Sudan and Marburg are among the world’s deadliest viruses, causing hemorrhagic fever with subsequent death in an average of 50 percent of cases.2,3
“Even as the world struggles with the COVID-19 pandemic, disease caused by Ebola Sudan and Marburg viruses continue to be a serious threat, as we have seen with the recent outbreak of Marburg in Guinea. We are grateful for BARDA’s continued support of Sabin’s efforts to advance vaccines against these deadly viruses,” said Sabin Chief Executive Officer Amy Finan. “We also thank our partners at the Vaccine Research Center of the NIH National Institute of Allergy and Infectious Diseases for their continued collaboration, and GSK for their earlier work on the candidates.”
The two candidate vaccines, based on GSK’s proprietary ChAd3 platform, were exclusively licensed to the Sabin Vaccine Institute from GSK in 2019.
This project has been funded in whole or in part with federal funds from the U.S. Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority, under contract number 75A50119C00055.
This above is the official Sabin Inst. press release, this below isn’t:
November 4, 2021 – The U.S. CDC published a Level Three Travel Advisory for the recent Ebola outbreak in the Beni Health Zone of the Democratic Republic of the Congo.
November 3, 2021 – The U.S. CDC vaccine advisory committee reviewed previous recommendation preexposure vaccination with Ervebo for adults aged ≥18 years in the U.S. population who are at highest risk for potential occupational exposure to Ebola virus species Zaire ebolavirus because they are: responding to an outbreak of Ebola Virus Disease (EVD), or work as health care personnel at federally designated Ebola treatment centers in the U.S., or work as laboratorians or other staff at biosafety level 4 facilities in the U.S.
November 2, 2021 – The WHO reported additional cases and deaths confirmed in the Ebola virus disease outbreak in the Democratic Republic of the Congo with two new health areas affected. A total of 394 people (67 primary care providers including nine high-risk contacts, nine contacts of contacts, and 49 probable contacts) have been vaccinated including 182 contacts of contacts, 125 probable contacts, and 87 high-risk contacts.
October 29, 2021 – A Research Article – Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomized, placebo-controlled Phase II clinical trial in Africa – was published by the journal PLOS Medicine. Conclusion – The Ad26.ZEBOV and MVA-BN-Filo combo vaccination were well tolerated and immunogenic in healthy and HIV-infected African adults. Increasing the interval between vaccinations from 28 to 56 days improved the magnitude of humoral immune responses. Antibody levels persisted to at least 1 year, and an Ad26.ZEBOV booster vaccination demonstrated the presence of vaccination-induced immune memory. These data supported the approval by the European Union for prophylaxis against EBOV disease in adults and children ≥1 year of age.
October 27, 2021 – IAVI announced an award of up to US$126 million from the Biomedical Advanced Research and Development Authority to develop two recombinant vesicular stomatitis virus (rVSV)-vectored filovirus vaccine candidates. This award supports preclinical activities and includes options for clinical development up to and inclusive of a Phase II clinical trial of IAVI’s rVSV Sudan ebolavirus vaccine candidate (rVSVΔG-SUDV-GP). Optional work that would continue the development of IAVI’s Marburg virus vaccine candidate (rVSVΔG-MARV-GP) that is currently supported by the Defense Threat Reduction Agency of the U.S. Department of Defense could be funded at a later date.
“Vectored” means, most likely, mRNA or some other genetic / nanotech targeting technology.
October 20, 2021 – The WHO African Region reported 5 Ebola cases, and over 27,000 travelers have been screened in the DRC. Furthermore, over 116 people have been vaccinated.
October 17, 2021 – Africa News reported Ebola vaccinations started in Beni, DRC, after at least two people died due to the virus in October 2021. The WHO African Region Tweeted DRC Situation Report (17/10/21) 5 confirmed cases, three deaths, 369 contacts identified, and 308 contacts monitored.
October 13, 2021 – Democratic Republic of the Congo (DRC) health officials confirmed an Ebola vaccination campaign had launched in the North Kivu province where one confirmed Ebola case, plus three related suspected deaths, were recently reported. About 1,000 doses of the rVSV-ZEBOV Ebola vaccine and other medical supplies were delivered from the capital Kinshasa to Goma city in North Kivu. The DRC has more than 12,000 vaccine doses in Kinshasa that can be deployed if necessary.
October 10, 2021 – The WHO reported additional Ebola cases related to the recent DRC case of a 3-year-old boy. A cluster of three deaths (two children and their father) who were neighbors of the case. These three patients died on 14, 19, and 29 September 2021 after developing symptoms consistent with Ebola. However, none were tested for the virus. As of October 9th, a total of 148 contacts have been identified and are under follow-up by the local response team.
October 8, 2021 – A case of Ebola has been confirmed in the eastern Democratic Republic of the Congo, five months after the end of the most recent Ebola outbreak there. The child died on October 6th. It was not immediately known if the Ebola case was related to the 2018-20 outbreak that killed more than 2,200 people in eastern Congo or the flare-up that killed six people in 2021.
September 13, 2021 – A new study based in Sierra Leone concluded the Ebola vaccine regimen from Janssen – J&J. It was found well tolerated with no safety concerns in children aged 1–17 years and induced robust humoral immune responses, suggesting the suitability of this regimen for Ebola virus disease prevention in children.
August 31, 2021 – The government of Cote d’Ivoire has informed the WHO that a second laboratory has tested samples from a patient suspected of having Ebola and has found no evidence of the virus. Around a dozen WHO experts were mobilized to support the country’s efforts, and 5,000 Ebola vaccine doses which WHO had helped Guinea procure were sent from Guinea to Cote d’Ivoire.
August 23, 2021 – The WHO African region reported Ebola booster dose vaccinations in Sierra Leone following administration of the prime dose of the Johnson & Johnson Ebola vaccine in May 2021. Frontline health workers, practitioners of traditional medicines or traditional healers, and commercial motorbike riders who received the first dose are now given their second jab to maximize their protection against the disease.
August 17, 2021 – The WHO confirmed Cote d’Ivoire deployed 2,000 vaccine doses from Merck and around 3,000 vaccine doses manufactured by Johnson & Johnson – Janssen.
August 14, 2021 – The WHO Africa reported the Ministry of Health of Cote d’Ivoire today confirmed the country’s first case of Ebola since 1994. This came after the Institut Pasteur in Cote d’Ivoire confirmed the Ebola Virus Disease in samples collected from a patient hospitalized in Abidjan’s commercial capital after arriving from Guinea.
August 9, 2021 – The WHO confirmed ‘Marburg virus disease (MVD) is a highly virulent, epidemic-prone disease associated with high case fatality rates (CFR 24-90%). In the early course of the disease, the clinical diagnosis of MVD is difficult to distinguish from other tropical febrile illnesses because of the similarities in the clinical symptoms. Differential diagnoses to be excluded include Ebola virus disease, as well as malaria, typhoid fever, leptospirosis, rickettsial infection, and plague.’
June 15, 2021 – The Southwest National Primate Research Center at Texas Biomedical Research Institute (Texas Biomed) has been awarded more than $37 million from the U.S. National Institutes of Health to continue operations into 2026. The P51 grant, given by the NIH Office of Research Infrastructure Programs, provides essential funding to house and care for nearly 2,500 non-human primates that are part of life-science research programs at Texas Biomed and partners around the globe.
June 4, 2021 – Johnson & Johnson welcomed a new recommendation by the Strategic Advisory Group of Experts on Immunization for the WHO that supports the use of the Johnson & Johnson Ebola vaccine regimen both during outbreaks for individuals at some risk of Ebola exposure and preventively, in the absence of an outbreak, for national and international first responders in neighboring areas or countries where an outbreak might spread.
April 10, 2021 – The government of Sierra Leone and the WHO announced Johnson & Johnson had donated about 4,500 Zabdeno and Mvabea Ebola vaccines to Sierra Leone to help prevent any Ebola outbreak. The last Ebola outbreak in Sierra Leone was in 2016.
March 25, 2021 – Ohio Gov. Mike DeWine revealed health officials are monitoring 44 people who have returned from areas of Africa with active outbreaks of Ebola.
March 25, 2021 – Oregon public health officials announced they are monitoring four people who recently visited the West African countries of Guinea and the Democratic Republic of the Congo. Regions in each of these countries are currently experiencing outbreaks of Ebola virus disease. The Oregon Health Authority and local public health departments have been in contact with these individuals, considered “persons under monitoring” since they arrived in the state earlier in March 2021.
March 23, 2021 – The WHO African Region Tweeted Guinea Ebola outbreak Situation Report (22/03/21) 18 cases, nine deaths, 78 contacts, 82% monitored. And 3,905 people have been vaccinated.
March 13, 2021 – After a request from the Guinean authorities, Russia is considering supplying a domestic vaccine against the Ebola virus to the African country, reported TASS.
May 13, 2020 – BARDA Provides the Sabin Vaccine Institute with an Additional $20 Million for Further Development of Ebola Sudan and Marburg Vaccines
The Sabin Vaccine Institute (Sabin) and its partner ReiThera Srl today announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, has exercised the first two options, valued at $20 million, under the 2019 contract to advance the development of vaccines against Ebola Sudan and Marburg viruses through Phase 2 clinical trials. In September 2019, BARDA awarded Sabin a development contract, valued at $128 million, and provided the initial funding award of $20.5 million. This second $20 million award will enable the manufacture and release of clinical vaccine material developed by ReiThera, a specialist in the development and cGMP manufacture of adenoviral vector vaccines. The funding will also support non-clinical studies to evaluate efficacy and immune response.
UPDATE 5: NOVEMBER 7, 2021: MARBURG GOES VIRAL ON INTERNET ONLY, YET. I’m happy awareness increases, it’s crucial. I’ve addressed this virus below, but not many had the patience to go through all text, and I kind of understand them, but there’s no easier way than reading. Here’s another angle to keep in sight when computing all this info:
UPDATE 4: OCTOBER 19 2021: THE FEARPORN CAMPAIGN TAKES SPEED AS IF THEY ARE TO RELEASE THIS SOON. IF YOU FALL FOR THEIR BRAINWASH, THEY HAVE NO REASON TO STOP.
And they’re still not running out of stupid ideas we can see through:
Oh, look who pushes the fear! Exactly who I would’ve expected:
Later update: In the meantime I’ve learned that Marburg (an Ebola relative) and Xinjiang fever, a Chinese relative of the Yellow Fever virus, are also top candidates, and that goes in line with the Fauci e-mails I highlighted below. I will be back with more details shortly. Almost certainly it will be some form of hemorrhagic fever, most likely to cover for injections side-effects on the blood stream.
UPDATE 2:
One month later, they’re starting to catch up and it’s still not too late to un-play it if this goes BOOM NOW!
By the end of last century, The Military has abandoned you and has joined Pharmafia and the super-rich elites in a plan to govern you with bioweapons and psy-ops. As I’ve said many times, Big Pharma and Big Tech are long gone, The Military BioTech Complex has been running the show for quite a while. This is just a chapter from that book, more to come if we get some love.
Canadian lab’s shipment of Ebola, Henipah viruses to China raises questions
Henipah and Nipah are interchangeable
Scientists at the National Microbiology Lab sent live Ebola and Henipah viruses to Beijing on an Air Canada flight March 31, and while the Public Health Agency of Canada says all federal policies were followed, there are questions about whether that shipment is part of an ongoing RCMP investigation.
Ebola and Henipah are Level 4 pathogens, meaning they’re some of the deadliest viruses in the world. They must be contained in a lab with the highest level of biosafety control, such as the one in Winnipeg.
Two months after that shipment, on May 24, the Public Health Agency of Canada (PHAC) referred an “administrative matter” to RCMP that resulted in the removal of two Chinese research scientists — Xiangguo Qiu and Keding Cheng — and several international students on July 5.
Both agencies have said repeatedly that public safety has not been at risk.
PHAC will not confirm if the March 31 shipment is part of the RCMP investigation.
Strict protocols
Several sources, who have asked to remain anonymous because they fear for their jobs, say the pathogens may have been shipped to the Chinese Academy of Sciences in a way that circumvented the lab’s operating procedures, and without a document protecting Canada’s intellectual property rights.
Researchers working at the National Microbiology Lab on cutting-edge, high-containment research are not allowed to send anything to other countries or labs without the intellectual property office negotiating and having a material transfer agreement in place, in case the material sent leads to a notable discovery.
A PHAC spokesperson did not confirm if this shipment included such an agreement.
However, Eric Morrissette said it’s “routine” for the lab to share samples of pathogens and toxins with partners in other countries to advance scientific work worldwide.
“All transfers of Risk Group 4 samples follow strict transportation requirements and are authorized by senior officials at the lab and the NML tracks and keeps electronic records of all shipments of samples in accordance with the HPTA. Agreements for the transfer of materials are determined on a case-by-case basis,” Morrisette wrote in an email statement.
“On the specific shipments to China earlier this year, we can confirm that we have all records pertaining to the shipment, and that all protocols were followed as directed by the above Acts and Standards.”
Sources say Xiangguo Qiu and her husband, Keding Cheng, were escorted from the National Microbiology Lab in Winnipeg on July 5. (Governor General’s Innovation Awards)
Xiangguo Qiu is head of the National Microbiology Lab’s Vaccine Development and Antiviral Therapies section in the Special Pathogens Program. She is responsible for the lab that works with Ebola. Her husband, Keding Cheng, is also a PHAC biologist.
After their security clearance was revoked and they were escorted from the lab, the University of Manitoba also cut ties with them and re-assigned Qiu’s graduate students, pending the RCMP investigation. No charges have been laid.
Neither scientist has responded to requests for comment, although some of their former colleagues say Qiu is not just a world-renowned scientist who helped develop a treatment for Ebola, but also a researcher with ethics and integrity.
Case raises questions
One question raised by this case is that of intellectual property protection, says Leah West, who practises, studies and publishes in the field of national security law and lectures at the Norman Paterson School of International Affairs.
“If China was leveraging these scientists in Canada to gain access to a potentially valuable pathogen or to elements of a virus without having to license the patent … it makes sense with the idea of China trying to gain access to valuable IP without paying for it,” she said.
Leah West says she hopes the lab and Health Canada are doing an investigation in addition to the one the RCMP is conducting. (Submitted by Leah West)
West accepts PHAC’s assertion that public safety is not an issue, even though the viruses were transported on a commercial Air Canada flight.
However, she says the fact the RCMP is involved means there’s a legitimate concern.
“You don’t send a policy breach, a bureaucratic policy breach, to the RCMP to investigate unless you believe that that policy breach has resulted in a criminal offence or could have resulted in a criminal offence. So what is the criminal offence potentially here?” West said.
She said she hopes the lab and Health Canada are also doing an internal investigation.
“I think there will need to be an inquiry into the scientists to potentially see whether or not they were compromised or any elements of their work were compromised and that China gained illegal or improper access to Canadian intellectual property … to see what China may have gained access to without knowledge, prior to this incident,” West says.
Don’t ‘jump into any conclusions too quickly’
However, the deputy director of the University of Alberta’s China Institute is urging caution when it comes to making assumptions.
Jia Wang doesn’t dispute China has been involved in the past in espionage and intellectual property theft, but she says that country is making big investments in developing STEM (science, technology, engineering and mathematics) scholars and then putting that into innovation.
China has its own reasons to protect intellectual property because many new ideas are coming from there, Wang says.
She’s waiting to see what comes of the RCMP investigation of the lab in Winnipeg.
“As China observers, we’d like to perhaps gently remind people not to jump into any conclusions too quickly,” she said.
“It will be good to get to the bottom of this and see what might have gone wrong and what was the oversight and how can the procedures be improved or people involved can be reminded of how to adhere to the policies better.”
Jia Wang, deputy director of the University of Alberta’s China Institute, is advising caution about making assumptions concerning the case. (Submitted by Jia Wang)
The shipment of the viruses took place at a time when relations between Canada and China have been strained over the arrest of a Huawei executive, at the request of the United States.
In retaliation, China has detained two Canadians and is boycotting Canadian canola and pork.
Because of the strained relationship between the two countries, and this case at the lab, Chinese-Canadian researchers and academics are starting to worry they may be singled out and targeted, Wang said.
“Certain assumptions are made or their loyalty to Canada is questioned in any way. And as multicultural as we are in Canada, we don’t want to see that.” – CBC, 2019
On December 19, 2019, the U.S. Food and Drug Administration announced the approval of Ervebo to prevent EVD caused by Zaire ebolavirus in individuals 18 years of age and older. This report, published by the U.S. CDC on January 8, 2021, summarizes the Advisory Committee on Immunization Practices (ACIP) recommendations for using the rVSVΔG-ZEBOV-GP Ebola vaccine (Ervebo) in the USA.
On July 1, 2020, the European Medicines Agency granted Johnson & Johnson Janssen’s Zabdeno and Mvabea Ebola vaccine therapy, a prime-boost vaccination approach for preventing infectious diseases. Janssen’s Ebola vaccine regimen is specifically designed to induce long-term immunity against the Ebola virus in adults and children aged one year and above.
CanSino Biologics’s Ad5-EBOV Ebola vaccine received approval in China in October 2017. Ad5-EBOV is an adenovirus type 5 vector-based Ebola virus disease vaccine that protects against Ebola by relying on the recombinant replication-defective human adenovirus type-5 vector immune response. In addition, Ad5-EBOV is manufactured as a lyophilized powder, highly stable, and does not require storage at ultra-low temperatures. This feature renders it viable for use in resource-limited tropical areas.
The WHO published the revised Ebola Vaccine FAQ on January 11, 2020.
Henipaviruses belong to the family of paramyxoviruses. Two species have been identified to be zoonotic, causing disease in animals. These are the Hendra virus (HeV) and the Nipah virus (NiV). They produce severe and often fatal illness in humans and horses.
Samples from early Wuhan COVID-19 patients show the presence of genetically modified Henipah virus, an American scientist has found.
Henipah was one of the two types of viruses sent to China by Chinese-born scientists from a Canadian laboratory at the centre of a controversy over the firing of the scientists and collaboration with Chinese military researchers. It is not clear whether the virus found in the Chinese samples is related to the samples sent by the Canadian lab, which were shipped in late March 2019.
The finding was confirmed for The Epoch Times by another qualified scientist.
The evidence was first found by Dr. Steven Quay, a Seattle-based physician-scientist and former faculty member at the Stanford University School of Medicine, who looked at early COVID-19 samples uploaded by scientists at the Wuhan Institute of Virology (WIV) shortly after China informed the World Health Organization about the SARS-CoV-2 outbreak.
Chinese virologist Shi Zhengli is seen inside the P4 laboratory in Wuhan, China, on Feb. 23, 2017. (Johannes Eisele/AFP via Getty Images)
The samples from the patients, who reportedly were found to have the “unknown pneumonia” in December 2019, were uploaded to the genetic sequence database, GenBank, on the website of the U.S. National Institute of Health (NIH).
Quay says that while other scientists around the world were mostly interested in examining the genome of SARS-CoV-2 in the samples uploaded by the WIV scientists, he wanted to see what else was in the samples collected from the patients.
So he collaborated with a few other scientists to analyze sequences from the samples.
“We started fishing inside for weird things,” Quay told The Epoch Times.
What they found, he says, are the results of what could likely be contamination from different experiments in the lab making their way into the samples, as well as evidence of Henipah virus.
“We found genetic manipulation of the Nipah virus, which is more lethal than Ebola.” Nipah is a type of Henipah virus.
The Epoch Times asked Joe Wang, PhD, who formerly spearheaded a vaccine development program for SARS in Canada with one of the world’s leading pharmaceutical companies, to verify the finding. Wang is currently the president of NTD Television Canada, the sister company of The Epoch Times in Canada.
After examining the evidence, Wang said he was able to replicate Quay’s findings on the Henipah virus. He explains that the genetic manipulation of the virus was likely for the purposes of vaccine development.
Winnipeg Lab
The firing of Chinese-born scientist Xiangguo Qiu and her husband, Keding Cheng, from the National Microbiology laboratory (NML) in Winnipeg has been the subject of much controversy in Canada, with opposition parties pressing the government for more details on the case, and the government refusing to release information citing national security and privacy concerns.
Qiu and Cheng along with several Chinese students were escorted out of NML, Canada’s only Level 4 lab, in July 2019, amid a police investigation. The two scientists were formally fired in January 2021.
The Public Health Agency of Canada (PHAC), which is in charge of NML, said the termination was the result of an “administrative matter” and “possible breaches of security protocols,” but has declined to provide further details, citing security and privacy concerns.
House Speaker Anthony Rota admonishes Public Health Agency of Canada President Iain Stewart in the House of Commons on June 21, 2021, for failing to provide documents related to the firing of two scientists from the National Microbiology Laboratory in Winnipeg. (The Canadian Press/Sean Kilpatrick)
During her time at NML, Qiu travelled several times in an official capacity to WIV, helping train personnel on Level 4 safety. The Globe and Mail later reported that scientists at NML have been collaborating with Chinese military researchers on deadly pathogens, and that one of the Chinese military researchers worked at the high-security Winnipeg lab for a period of time.
Documents and emails released by PHAC show that the shipment of Henipah and Ebola samples was done with the permission of NML authorities.
In one of the emails sent in September 2018, David Safronetz, chief of special pathogens at PHAC, informs then-head of NML Matthew Gilmour and other lab administrators about the request from WIV for the shipment of the samples, saying “I trust the lab.”
In response, Gilmour asks about the nature of the work that will be done at the Wuhan lab, and why the lab doesn’t get the material from “other, more local labs.” He also tells Safronetz that it’s “good to know that you trust this group,” asking how NML was connected with them.
In his reply, Safronetz doesn’t specifically say what the samples will be used for in China, but notes they will only be sent once all paperwork and certification is completed. He also says the WIV is requesting the material from NML “due to collaboration” with Qiu.
He adds, “Historically, it’s also been easier to obtain material from us as opposed to US labs. I don’t think other, closer labs have the ability to ship these materials.”
Gilmour resigned from his position at NML in May 2020 and joined a UK-based bioresearch company.
MPs have asked NML management why shipment of the samples was allowed and whether they knew if China performs any Gain of Function (GoF) research at WIV. GoF research involves increasing the lethal level (virulence) or transmissibility of pathogens.
NML’s acting scientific director general Guillaume Poliquin told MPs during a parliamentary committee meeting on March 22 that the lab only sent the samples to WIV after receiving assurance that no GoF research would take place.
Conservative MP John Williamson pressed for more answers, saying the word of the state-run Chinese lab can’t be trusted as the Chinese regime “has a history of theft and lies.”
The issue of GoF research at WIV has been a point of contention in the United States between lawmakers and Dr. Anthony Fauci, NIH’s head of the National Institute of Allergy and Infectious Diseases, whose organization has funded research (through EcoHealth Alliance) on coronaviruses at the Wuhan lab. U.S. Sen. Rand Paul says published work from WIV on coronaviruses shows the lab is conducting GoF research, a charge Fauci denies.
The P4 laboratory on the campus of the Wuhan Institute of Virology in Wuhan, China, on May 13, 2020. (Hector Retamal/AFP via Getty Images)
The Epoch Times sought comment from PHAC, including as to how the agency addressed issues of intellectual property and the development of any products such as vaccines with WIV, but didn’t hear back by time of publication.
Despite repeated requests by opposition parties for more details related to the firing of the two NML scientists, the Liberal government has refused to provide records, saying there are national security and privacy concerns.
After the House of Commons issued an order for the government to disclose the information, the government took the Speaker of the House to court to obtain confirmation from a judge that it can withhold the documents. The government later dropped its court case once Prime Minister Justin Trudeau called an election and Parliament was dissolved. – Epoch Times
UPDATE 3: I FOUND CREDIBLE SOURCES FOR MOST OF DR. ARYANA LOVE’S EXPLOSIVE CLAIMS BELOW:
I didn’t have an in depth look at all her sources, I can’t have a final 100% verdict, but I did more than a glance and no lies detected. You can review her blog post yourself HERE. This might be the closure to this report and the start for another.
OBAMA: EBOLA RESPONSE A TRIAL RUN FOR A POTENTIAL AIRBORNE VIRUS THAT MIGHT HIT SOON (2014)
BONUS
This is from 2014, but the story goes a way long back. And forward. Let’s not forget Putin is a Davos regular since before he became such a literal czar.
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
March 31, 2021 (LifeSiteNews) –– A host of global leaders issued a call for a global pandemic treaty, purportedly in order to prevent future pandemics, distribute vaccinations, and implement a unilateral approach to global governance.
U.K. Prime Minister Boris Johnson, French President Emmanuel Macron, German Chancellor Angela Merkel, the head of the World Health Organisation (WHO), as well as 20 other world leaders, joined forces in penning a joint letter with the apparent intent of winning popular support for the globalist plan.
Writing in U.K. paper The Telegraph, as well as other publications such as Le Monde in France, the leaders declared their intent to “build a more robust international health architecture that will protect future generations.”
Calling COVID-19 the “biggest challenge to the global community since the 1940s,” the 24 leaders predicted that there “will be other pandemics and other major health emergencies.”
“No single government or multilateral agency can address this threat alone,” they declared. “The question is not if, but when. Together, we must be better prepared to predict, prevent, detect, assess and effectively respond to pandemics in a highly co-ordinated fashion. The Covid-19 pandemic has been a stark and painful reminder that nobody is safe until everyone is safe.”
This final phrase could indicate the influence which World Economic Forum (WEF) founder and committed globalist Klaus Schwab enjoys over the 24 leaders. Just weeks ago, Schwab declared, “As long as not everybody is vaccinated, nobody will be safe,” a statement which in itself poses an interesting question about the trust which such leaders are placing in their much praised, but dangerous, experimental injections.
The leaders re-affirmed their joint aim of global vaccination, describing it as “global public good.”
In order to achieve that “public good,” and to ensure swift roll-out of vaccines across the globe, the 24 globalists initiated their new international treaty: “[W]e believe that nations should work together towards a new international treaty for pandemic preparedness and response. Such a renewed collective commitment would be a milestone in stepping up pandemic preparedness at the highest political level.”
This treaty would be based on the principles of the WHO, drawing from the WHO’s constitution, as well as calling on “other relevant organisations key to this endeavour.” The WHO’s director-general, Dr. Tedros Adhanom Ghebreyesus, was one of the signatories of the statement.
“The main goal of this treaty would be to foster an all of government and all of society approach, strengthening national, regional and global capacities and resilience to future pandemics,” the leaders declared.
“This includes greatly enhancing international co-operation to improve, for example, alert systems, data-sharing, research and local, regional and global production and distribution of medical and public health counter-measures such as vaccines, medicines, diagnostics and personal protective equipment.”
Nor would it be centered purely on globalist vaccination agendas. Due to the leaders’ “One Health” approach, it would build on the principle of a connection between “the health of humans, animals and our planet.”
In language reminiscent of the Great Reset agenda, promoted by the WEF and Klaus Schwab, the leaders mentioned that the new treaty would lead to a lack of national interests, and increased international concerns: “[S]uch a treaty should lead to more mutual accountability and shared responsibility, transparency and co-operation within the international system and with its rules and norms.”
No section of society would be exempt from becoming involved in the new treaty, whatever it may turn out to look like, with the world leaders pointing out that “we will work with heads of state and governments globally, and all stakeholders including civil society and the private sector.”
Declaring that the coronavirus, which originated in Wuhan, China, had “exploited our weaknesses and divisions,” the leaders pronounced it to be their “responsibility” to “ensure that the world learns the lessons of the Covid-19 pandemic,” and to “seize this opportunity and come together as a global community for peaceful co-operation that extends beyond this crisis.”
The proposal is due to be further discussed among national leaders at the June G7 summit in Cornwall in the U.K., where Boris Johnson will join his counterparts from Canada, France, Germany, Italy, Japan, the U.S., and the E.U. Meanwhile, the 24 signatories warned that their new plan “will take time and require a sustained political, financial and societal commitment over many years.”
Speaking to BBC Radio, the WHO’s special COVID envoy Dr. David Nabarro, echoed the language employed by the 24 leaders, noting that it would be 2022 before the globalist agenda of world vaccination was complete, and thus hinted at “all sorts of problems with variants,” before that goal was complete.
The planned treaty appears to align very closely with the Great Reset goals of Klaus Schwab. The World Economic Forum’s promotion of the Reset even employs matching terminology, describing “leaders” who “find themselves at a historic crossroads.”
The societal disruption caused by the Wuhan virus presents “a unique window of opportunity to shape the recovery” for Schwab, who added that “this initiative will offer insights to help inform all those determining the future state of global relations, the direction of national economies, the priorities of societies, the nature of business models and the management of a global commons.”
Indeed, the link between the new international treaty and the Great Reset caused veteran presenter Richie Allen to write, “This is terrifying. For many years, I have been featuring writers, researchers and academics who warned us that this would happen. This is the end game.”
Such a treaty was simply about “concentrating power in the hands of a tiny elite,” explained Allen. “It’s what globalists have been working towards for decades.”
The full list of signatories is found below:
J. V. Bainimarama, prime minister of Fiji; António Luís Santos da Costa, prime minister of Portugal; Klaus Iohannis, president of Romania; Boris Johnson, prime minister of the United Kingdom; Paul Kagame, president of Rwanda; Uhuru Kenyatta, president of Kenya; Emmanuel Macron, president of France; Angela Merkel, chancellor of Germany; Charles Michel, president of the European Council; Kyriakos Mitsotakis, prime minister of Greece; Moon Jae-in, president of the Republic of Korea; Sebastián Piñera, president of Chile; Carlos Alvarado Quesada, president of Costa Rica; Edi Rama, prime minister of Albania; Cyril Ramaphosa, president of South Africa; Keith Rowley, prime minister of Trinidad and Tobago; Mark Rutte, prime minister of the Netherlands; Kais Saied, president of Tunisia; Macky Sall, president of Senegal; Pedro Sánchez, Prime Minister of Spain; Erna Solberg, prime minister of Norway; Aleksandar Vučić, president of Serbia; Joko Widodo, president of Indonesia; Volodymyr Zelensky, president of Ukraine; Dr. Tedros Adhanom Ghebreyesus, director-general of the World Health Organisation.
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
We gave up on our profit shares from masks, if you want to help us, please use the donation button! We think frequent mask use, even short term use can be bad for you, but if you have no way around them, at least send a message of consciousness. Get it here!
He’s a former member of Bilderberg’s Steering Group. Unsurprisingly, I admit, but wait.
Bilderberg is governed by a Steering Committee which designates a Chairman; members are elected for a term of four years and can be re-elected. There are no other members of the Bilderberg conference.The Chair’s main responsibilities are to chair the Steering Committee and to prepare with the Steering Committee the conference program, the selection of participants. He also makes suggestions to the Steering Committee regarding its composition. The Executive Secretary reports to the Chairman. – Source
Last few years, he’s been preparing to step down from the WEF leadership, which will be taken over by a team. We don’t know who’s in this team, but I’ll shave my head if China isn’t well represented.
2015 interview
4.
Klaus Schwab is also very involved with another elite organization that studies how to change The Universal Declaration of Human Rights so they can harmonize it with the globalist agenda that includes a global citizenship, among others.
The Global Citizenship Commission was convened, under the leadership of former British Prime Minister Gordon Brown and the auspices of NYUs Global Institute for Advanced Study, to re-examine the spirit and stirring words of The Universal Declaration of Human Rights. The result this volume offers a 21st-century commentary on the original document, furthering the work of human rights and illuminating the ideal of global citizenship. What does it mean for each of us to be members of a global community? Since 1948, the Declaration has stood as a beacon and a standard for a better world. Yet the work of making its ideals real is far from over. Hideous and systemic human rights abuses continue to be perpetrated at an alarming rate around the world. Too many people, particularly those in power, are hostile to human rights or indifferent to their claims. Meanwhile, our global interdependence deepens. Bringing together world leaders and thinkers in the fields of politics, ethics, and philosophy, the Commission set out to develop a common understanding of the meaning of global citizenship one that arises from basic human rights and empowers every individual in the world. This landmark report affirms the Universal Declaration of Human Rights and seeks to renew the 1948 enterprise, and the very ideal of the human family, for our day and generation. Members of the Global Citizenship Commission include: K. Anthony Appiah, Laurel Bellows, Nicolas Berggruen, Paul Boghossian, Gordon Brown (Chair), Craig Calhoun, Wang Chenguang, Mohamed ElBaradei, Fonna Forman, Andrew Forrest, Ronald M. George, Asma Jahangir, John Kufuor, Graça Machel, Catherine ORegan, Ricken Patel, Emma Rothschild, Robert Rubin, Jonathan Sacks, Kailash Satyarthi, Klaus Schwab , Amartya Sen, John Sexton, Robert Shrum, Jeremy Waldron, Joseph Weiler, Rowan Williams, Diane C. Yu (Executive Director).”-Source -Publisher’s press release.
On 9/11, the founder and president of the World Economic Forum, Klaus Schwab, was having breakfast with Rabbi Arthur Schneier at his Park East Synagogue in New York when the two jets struck the World Trade Center, Schneier said. Schneier, who heads the Appeal of Conscience Foundation, a coalition of business and religious leaders in New York, had intended to discuss increasing the participation of religious leaders at the economic forum. After the attack, the notion seemed even more urgent. With Schneier´s assistance, Schwab decided to commemorate the world disaster by moving his forum — traditionally held in the Swiss ski resort of Davos — to New York City, Schneier said. And he doubled the number of religious leaders to 40, including eight Jews. While Western nations have distanced religion from public life in recent decades, the forum´s new line is to embrace religion, understand its traditions and glean its wisdom. As international companies expand their markets and governments and corporations see peace as essential to progress, leaders increasingly are giving religion a role in enhancing international stability. – Source
I don’t know when you started counting, but Klaus Schwab was already at “Globalism 4.0” during the World Government Summit of 2019. Did you even know there was a World Government Summit? I admit I’ve missed this one until recently.
Indeed, he has declared “old-school” globalization completed in 2017. Plebs are still accommodating with the concept.
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
This has been revealed to me while investigating Trump’s new “Vaccine Czar” Moncef Slaoui, in his home-town Agadir, Morocco, under a coronavirus lockdown and a hunger-strike. Energy and time are scarce, I’ll be making a brief sum-up here, and for more details please read my other investigations on this site.
The scheme is simple and efficient:
Bill Gates: Money, influence and organizing
Tony Fauci (NIAID): Influence, research and power
through US Government and media with all their capabilities
Moncef Slaoui (GSK, Moderna), US’ new “Vaccine Czar”: concocts the vaccines, connects the industry
Together they control WHO and GAVI, which serve as common platforms and global marketers
The following vaccines have been elaborated and marketed by this group, mostly with disastrous effects:
There were no serious adverse events that could be attributable to the vaccine. We’re seeing pain, redness and perhaps some swelling that we see very frequently with injectable vaccines.
“This is not the big game changer that we were hoping for,” said Dr. Martin De Smet, a malaria expert at Doctors Without Borders. “The vaccine itself remains disappointing but this is an important step forward,” he said. Still, De Smet said the vaccine could help reduce the huge burden of malaria: there are about 200 million cases and more than 500,000 deaths every year, mostly in African children.
“The summit aims to raise at least $7.4 billion (approx. £6 billion) for Gavi to immunise a further 300 million children in the world’s poorest countries by 2025.” – https://www.gov.uk/
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
Sometimes my memes are 3D. And you can own them. Or send them to someone. You can even eat some of them. CLICK HERE
SILVIEW.media 